达沙替尼药品市场：按类型、按适应症、按配销通路、按地区

Dasatinib Drugs Market, By Type, By Indication, By Distribution Channel, By Geography

出版日期: 2023年11月08日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

全球达沙替尼药品市场规模预计将从 2023 年的 14.65 亿美元增至 2030 年的 21.987 亿美元，2023-2030 年预测期间复合年增长率为 6%。

报告范围		报告详情
基准年	2022年	2023年市场规模	14.65亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期复合年增长率	6.00%	2030年市场规模预测	21.987 亿美元

图 1. 2023 年达沙替尼药物全球市场占有率(%)，依地区划分

达沙替尼是一种酪胺酸激化酵素抑制剂，彻底改变了某些癌症类型的治疗方法。达沙替尼最初是作为慢性骨髓性白血病(CML) 和费城染色体阳性急性淋巴细胞白血病 (Ph+ALL) 的标靶治疗而开发的，它特异性靶向并抑制BCR-ABL 蛋白，从而抑制细胞生长和增殖。达沙替尼疗效显着，显着改善了这些恶性患者的预后和存活率。此外，达沙替尼也对其他酪胺酸激酶（包括SRC家族激酶）表现出抑製作用，扩大了其应用于多种肿瘤的可能性。儘管达沙替尼是一种有前途的治疗选择，但它并非没有副作用，需要仔细监测和管理。正在进行的研究和临床试验正在探索达沙替尼在联合治疗中的潜力，为癌症治疗策略的进一步进展铺平道路。

市场动态：

癌症发生率的增加、良好的临床结果以及核准适应症的扩大预计将在预测期内推动达沙替尼药物全球市场的成长。此外，标靶治疗的开拓预计也将在预测期内推动全球达沙替尼药物市场的成长。新兴市场开拓、联合治疗、儿童适应症和仿製药开发预计将为预测期内全球达沙替尼药物市场的成长提供成长机会。

然而，高昂的治疗成本、严格的监管要求、潜在的副作用以及抗药性细菌的出现预计将阻碍达沙替尼药物市场在预测期内的成长。

本研究的主要特点

本报告对全球达沙替尼药物市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030年）的市场规模和復合年增长率。
它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球达沙替尼製药市场的主要企业。
该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
达沙替尼药品全球市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球达沙替尼药物市场的各种策略矩阵来促进他们的决策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 1,465.0 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	6.00%	2030 Value Projection:	US$ 2,198.7 Mn

Dasatinib is a potential tyrosine kinase inhibitor that has revolutionized the treatment landscape for certain types of cancer. Initially developed as a targeted therapy for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), dasatinib specifically targets and inhibits the BCR-ABL protein, suppressing the growth and proliferation of cancer cells. With remarkable efficacy, dasatinib has significantly improved outcomes and increased survival rates in patients with these malignancies. Moreover, dasatinib exhibits inhibitory effects on other tyrosine kinases, including SRC family kinases, broadening its potential application to various tumors. While dasatinib offers a promising therapeutic option, it is not without side effects, necessitating careful monitoring and management. Ongoing research and clinical trials are exploring the potential of dasatinib in combination therapies, paving the way for further advancements in cancer treatment strategies.

Market Dynamics:

The increasing prevalence of cancer, favorable clinical outcomes, and expansion of approved indications are anticipated to drive the growth of the global dasatinib drugs market over the forecast period. Moreover, the development of targeted therapies is also expected to boost the growth of the global dasatinib drugs market over the forecast period. Expansion into emerging markets, combination therapies, pediatric indications, and the development of generic versions are expected to create growth opportunities for the global dasatinib drugs market growth during the forecast period.

However, the high cost of treatment, stringent regulatory requirements, potential adverse effects, the development of resistance are expected to hamper the growth of the dasatinib drugs market over the forecast period.

Key features of the study:

This report provides an in-depth analysis of the global dasatinib drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global dasatinib drugs market based on the following parameters - company highlights, product portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bristol-Myers Squibb Company, MSN Labs, Lupin, Dr. Reddy's Laboratories, Gilead Sciences, Inc., Hetero Labs, MANUS AKTTEVA BIOPHARMA LLP, Alembic Pharma, JINLAN Pharm-Drugs Technology Co., Ltd., and Zhejiang Hisun Pharma
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global dasatinib drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dasatinib drugs market

Detailed Segmentation:

Dasatinib Drugs Market, By Type:
- 20 mg
- 50 mg
- 70 mg
Dasatinib Drugs Market, By Indication:
- Chronic Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Others
Dasatinib Drugs Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Dasatinib drugs market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- Bristol-Myers Squibb
- MSN Labs
- Lupin
- Dr. Reddy's Laboratories
- Hetero Labs
- MANUS AKTTEVA BIOPHARMA LLP
- Alembic Pharma
- JINLAN Pharm-Drugs Technology Co., Ltd.
- Reddy's Laboratories
- Zhejiang Hisun Pharma

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Type
- Market Snippet, By Indication
- Market Snippet, By Distribution channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing prevalence of cancer
- Restraints
Increasing product recall
- Opportunities
Expansion into emerging markets
Combination therapies
Pediatric indications
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Dasatinib Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Dasatinib Drugs Market, By Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
20 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
50 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
70 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Dasatinib Drugs Market, By Indication, 2023-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Chronic Myeloid Leukemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Acute Lymphoblastic Leukemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Dasatinib Drugs Market, By Distribution Channel, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

8. Dasatinib Drugs Market, By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
U.S.
Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
North Africa
South Africa
Central Africa